Literature DB >> 17106933

Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats.

Ali-Riza Soylu1, Nurettin Aydogdu, Umit-Nusret Basaran, Semsi Altaner, Orhan Tarcin, Nursal Gedik, Hasan Umit, Ahmet Tezel, Gulbin Dokmeci, Huseyin Baloglu, Mevlut Ture, Kemal Kutlu, Kadir Kaymak.   

Abstract

AIM: To investigate whether antioxidants vitamin E and C can retard development of hepatic fibrosis in the biliary-obstructed rats.
METHODS: Fifty Wistar albino rats were randomly assigned to 5 groups (10 rats in each). Bile duct was ligated in 40 rats and they were treated as follows: group vitC, vitamin C 10 mg/kg sc daily; group vitE, vitamin E 15 mg/kg sc daily; group vitEC, both of the vitamins; bile duct-ligated (BDL, control) group, physiological saline sc. The fifth group was assigned to sham operation. At the end of fourth week, the rats were decapitated, and hepatic tissue biochemical collagen content and collagen surface area were measured. Hepatic tissue specimens were histopathologically evaluated according to Scheuer system. Serum hyaluronate levels were measured by ELISA method.
RESULTS: Despite being higher than sham group, hepatic collagen level was significantly decreased in each of the vitC, vitE and vitEC groups (32.7 +/- 1.2, 33.8 +/- 2.9, 36.7 +/- 0.5 mug collagen/mg protein, respectively) compared to BDL (48.3 +/- 0.6 mg collagen/g protein) (P < 0.001 for each vitamin group). Each isolated vitamin C, isolated vitamin E and combined vitamin E/C supplementation prevented the increase in hepatic collagen surface density (7.0% +/- 1.1%, 6.2% +/- 1.7%, 12.3% +/- 2.0%, respectively) compared to BDL (17.4% +/- 5.6%) (P < 0.05 for each). The same beneficial effect of vitamin C, vitamin E and combined vitamin E/C treatment was also observed on the decrease of serum hyaluronate levels compared to BDL group (P < 0.001). The relative liver and spleen weights, serum transaminases, cholestatic enzymes, bilirubins and histopathological inflammation scores were not different between the antioxidant treatment groups and the control. However, fibrosis staging scores were obviously reduced only in the vitamin E/C combination group (vit EC: 2.4 +/- 0.8 vs BDL: 3.1 +/- 0.7; P < 0.05).
CONCLUSION: Each antioxidant vitamin E, vitamin C and their combination retard hepatic fibrosis in biliary-obstructed rats. Oxidative stress may play a role in the pathogenesis of hepatic fibrosis in secondary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106933      PMCID: PMC4087439          DOI: 10.3748/wjg.v12.i42.6835

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Matrix as a modulator of hepatic fibrogenesis.

Authors:  D Schuppan; M Ruehl; R Somasundaram; E G Hahn
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

2.  Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1.

Authors:  J D Jia; M Bauer; J J Cho; M Ruehl; S Milani; G Boigk; E O Riecken; D Schuppan
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

3.  Serum hyaluronan--a non-invasive test for diagnosing liver cirrhosis.

Authors:  J N Plevris; G H Haydon; K J Simpson; R Dawkes; C A Ludlum; D J Harrison; P C Hayes
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 2.566

4.  d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation.

Authors:  K Houglum; D A Brenner; M Chojkier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 5.  Oxidative damage and fibrogenesis.

Authors:  G Poli; M Parola
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  Stimulation of collagen alpha 1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?

Authors:  P Bedossa; K Houglum; C Trautwein; A Holstege; M Chojkier
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

7.  Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells.

Authors:  M Parola; M Pinzani; A Casini; E Albano; G Poli; A Gentilini; P Gentilini; M U Dianzani
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

8.  A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

Authors:  A López-De León; M Rojkind
Journal:  J Histochem Cytochem       Date:  1985-08       Impact factor: 2.479

9.  Antioxidant defenses in the bile duct-ligated rat.

Authors:  S Singh; G Shackleton; E Ah-Sing; J Chakraborty; M E Bailey
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

10.  Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver.

Authors:  M Parola; R Muraca; I Dianzani; G Barrera; G Leonarduzzi; P Bendinelli; R Piccoletti; G Poli
Journal:  FEBS Lett       Date:  1992-08-24       Impact factor: 4.124

View more
  15 in total

Review 1.  Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research-a review.

Authors:  Keerthana Prasad; Gopalakrishna K Prabhu
Journal:  J Med Syst       Date:  2011-05-17       Impact factor: 4.460

Review 2.  Food components with antifibrotic activity and implications in prevention of liver disease.

Authors:  Minkyung Bae; Young-Ki Park; Ji-Young Lee
Journal:  J Nutr Biochem       Date:  2017-11-16       Impact factor: 6.048

3.  Nesfatin-1 alleviates extrahepatic cholestatic damage of liver in rats.

Authors:  Ali Solmaz; Osman Bilgin Gülçiçek; Candaş Erçetin; Hakan Yiğitbaş; Erkan Yavuz; Sinan Arıcı; Can Erzik; Oğuzhan Zengi; Pelin Demirtürk; Atilla Çelik; Fatih Çelebi
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

4.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

5.  Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis.

Authors:  Ilker Tasci; Mehmet Refik Mas; Sevil Atalay Vural; Salih Deveci; Bilgin Comert; Gunay Alcigir; Nuket Mas; Cemal Akay; Mithat Bozdayi; Cihan Yurdaydin; Hakan Bozkaya; Ozden Uzunalimoglu; Ahmet Turan Isik; Harun M Said
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

6.  Quercetin treatment ameliorates systemic oxidative stress in cirrhotic rats.

Authors:  Emanuelle Kerber Vieira; Silvia Bona; Fábio Cangeri Di Naso; Marilene Porawski; Juliana Tieppo; Norma Possa Marroni
Journal:  ISRN Gastroenterol       Date:  2011-08-15

7.  Time course of collagen peak in bile duct-ligated rats.

Authors:  Orhan Tarcin; Metin Basaranoglu; Veysel Tahan; Gülgün Tahan; Ilker Sücüllü; Nevin Yilmaz; Gagan Sood; Ned Snyder; Gilbert Hilman; Cigdem Celikel; Nurdan Tözün
Journal:  BMC Gastroenterol       Date:  2011-04-28       Impact factor: 3.067

8.  Vitamin A supplementation alleviates extrahepatic cholestasis liver injury through Nrf2 activation.

Authors:  Guiyang Wang; Peng Xiu; Fu Li; Cheng Xin; Kewei Li
Journal:  Oxid Med Cell Longev       Date:  2014-07-09       Impact factor: 6.543

9.  Possible Involvement of Nitric Oxide in Enhanced Liver Injury and Fibrogenesis during Cholestasis in Cytoglobin-deficient Mice.

Authors:  Tuong Thi Van Thuy; Le Thi Thanh Thuy; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.